Moderna Inc (MRNA)
Pretax margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -3,607,000 | -2,353,000 | -4,332,000 | -4,802,000 | -3,942,000 | -2,357,000 | 818,000 | 5,041,000 | 9,575,000 | 13,330,000 | 15,665,000 | 16,254,000 | 13,285,000 | 7,603,988 | 3,819,216 | 639,651 | -744,513 | -597,910 | -488,510 | -507,323 |
| Revenue (ttm) | US$ in thousands | 3,229,000 | 5,076,000 | 5,052,000 | 5,155,000 | 6,826,000 | 9,097,000 | 10,486,000 | 14,708,000 | 18,810,000 | 20,675,000 | 22,284,000 | 21,933,000 | 17,736,000 | 11,016,375 | 6,199,591 | 2,013,033 | 274,490 | 55,668 | 56,790 | 38,378 |
| Pretax margin | -111.71% | -46.36% | -85.75% | -93.15% | -57.75% | -25.91% | 7.80% | 34.27% | 50.90% | 64.47% | 70.30% | 74.11% | 74.90% | 69.02% | 61.60% | 31.78% | -271.24% | -1,074.06% | -860.20% | -1,321.91% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-3,607,000K ÷ $3,229,000K
= -111.71%
The pretax margin of Moderna Inc has exhibited significant volatility over the analyzed period. Starting from negative values well above 1,000% in early 2020, the company managed to improve its financial performance notably. By the end of 2021 and the beginning of 2022, the pretax margin surpassed 70%, indicating a strong ability to generate profits before taxes relative to its total revenue. However, this positive trend started to decline gradually in the following quarters, with pretax margins dropping to around 50% by the end of 2022. Notably, in the last quarter of 2024, the pretax margin plummeted to approximately -111.71%, suggesting that the company's profitability before taxes experienced a significant downturn. Overall, Moderna Inc's pretax margin has shown fluctuations, but the company will need to carefully manage its cost structures and revenue streams to maintain sustainable profitability in the future.
Peer comparison
Dec 31, 2024